RITHOLTZ WEALTH MANAGEMENT

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 1698218 NEW YORK, NY

Position in TAK

as of Mar 31, 2026 · filed Apr 20, 2026 Compact

Position Value

$985,356

+$613,504 QoQ

Shares Held

53,205

+123.1% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

RITHOLTZ WEALTH MANAGEMENT holds $15,325,288 across 16 Drug Manufacturers - Specialty & Generic names. TAK ranks #7 (6.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INDV	Indivior Pharmaceuticals, Inc.	114,778	$3,498,433
2	ALKS	Alkermes plc.	45,844	$1,621,043
3	VTRS	Viatris Inc	104,828	$1,416,226
4	AMRX	Amneal Pharmaceuticals, Inc.	102,557	$1,274,783
5	BHC	Bausch Health Companies Inc.	222,459	$1,201,278
6	ZTS	Zoetis Inc.	9,842	$1,163,422
7	TAK	Takeda Pharmaceutical Co Ltd This page	53,205	$985,356
8	HLN	Haleon plc	97,069	$971,660

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$985,356	53,205	+123.1%	Shares	Sole	2026-04-20
2025-12-31	$371,852	23,852	-59.7%	Shares	Sole	2026-01-23
2025-09-30	$866,087	59,159	+149.1%	Shares	Sole	2025-10-28
2025-06-30	$367,113	23,746	+2.1%	Shares	Sole	2025-07-28
2025-03-31	$345,682	23,247	-7.9%	Shares	Sole	2025-04-17
2024-12-31	$334,031	25,229	-7.1%	Shares	Sole	2025-01-15
2024-09-30	$386,343	27,169	+11.7%	Shares	Sole	2024-10-10
2024-06-30	$314,687	24,319	+114.1%	Shares	Sole	2024-08-01
2023-09-30	$175,723	11,359	-3.8%	Shares	Sole	2023-10-13
2023-06-30	$185,582	11,813	—	Shares	Sole	2023-07-17
No filing history on record for this holder in this stock.